DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase II drugs for Anaplastic Astrocytoma have a 19% phase ...
Jayden, a 13-year-old boy, was diagnosed with a grade II diffuse astrocytoma, an inoperable brain tumor, in 2018 that also caused hydrocephalus. Despite undergoing three surgeries in three months, he ...
Contrast-enhanced MRI and fluorothymidine positron-emission tomography (PET) did not point toward neoplasm, a lesion biopsy, however, showed astrocytoma, which was confirmed as grade III astrocytoma ...
CAN-3110 is under clinical development by Candel Therapeutics and currently in Phase I for Anaplastic Astrocytoma. According to GlobalData, Phase I drugs for Anaplastic Astrocytoma have a 67% phase ...
Here we present a 35-year-old male with worsening auditory hallucinations after surgical resection and radiation of a right temporal lobe astrocytoma in the setting of co-morbid methamphetamine usage.